Search Results - "Sato, Shuichiro"
-
1
An Efficient and Practical Method for the Synthesis of the 5-Acylamino-4-(4-pyrimidinyl)isoxazole Derivative AKP-001, a Potent P38 MAP Kinase Inhibitor
Published in Heterocycles (01-05-2017)Get full text
Journal Article -
2
Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients
Published in International journal of cancer (15-05-2007)“…NY‐ESO‐1 specific humoral responses are frequently observed in patients with various types of NY‐ESO‐1 antigen expressing tumors. In a large proportion of…”
Get full text
Journal Article -
3
Spontaneous remission of a non-small cell lung cancer possibly caused by anti-NY-ESO-1 immunity
Published in Lung cancer (Amsterdam, Netherlands) (01-07-2009)“…Abstract Spontaneous remission of malignant tumors is rare and the biological mechanism of such remission has not been addressed. We report the case of a…”
Get full text
Journal Article -
4
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors
Published in Cancer research (Chicago, Ill.) (15-03-2004)“…NY-ESO-1 is a cancer/testis antigen expressed in normal adult tissues solely in the testicular germ cells of normal adults and in various cancers. It induces…”
Get full text
Journal Article -
5
XAGE-1 Expression in Non–Small Cell Lung Cancer and Antibody Response in Patients
Published in Clinical cancer research (01-08-2005)“…Purpose: XAGE-1 was originally identified by the search for PAGE/GAGE -related genes using expressed sequence tag database and was shown to exhibit…”
Get full text
Journal Article -
6
Identification of a CD4 T‐cell epitope in tumor rejection antigen RLakt on BALB/c radiation‐leukemia RL male 1
Published in Cancer science (01-07-2008)“…We have previously shown that the RLakt antigen was predominantly recognized by CD8 cytotoxic T lymphocytes (CTL) in RL male 1‐bearing or ‐rejected syngeneic…”
Get full text
Journal Article -
7
NY-ESO-1 Expression and Immunogenicity in Esophageal Cancer
Published in Clinical cancer research (01-10-2004)“…Purpose: Although NY-ESO-1 was isolated from an esophageal carcinoma patient, its expression in this type of cancer and its immunogenicity in esophageal cancer…”
Get full text
Journal Article -
8
Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma
Published in Journal of gastroenterology and hepatology (01-10-2004)“…Background and Aim: We analyzed the expression of antigen‐processing and antigen‐presenting molecules in surgically resected fresh samples of human…”
Get full text
Journal Article -
9
Identification of glioma‐specific RFX4‐E and ‐F isoforms and humoral immune response in patients
Published in Cancer science (01-11-2005)“…For regulatory factor X4 (RFX4), two alternatively spliced variants, RFX4‐A and ‐B, were reported in the testis. In this study, we identified transcript…”
Get full text
Journal Article -
10
HLA-DRB10410-Restricted Recognition of XAGE-1b37-48 Peptide by CD4 T Cells
Published in Microbiology and immunology (2007)“…XAGE‐1b belongs to cancer/testis (CT) antigens, and has been shown to be expressed frequently in lung cancers and to elicit an antibody response in patients…”
Get full text
Journal Article -
11
Over-Expression of the Testis-Specific Gene TSGA10 in Cancers and Its Immunogenicity
Published in Microbiology and immunology (01-01-2004)“…The TSGA10 gene was originally isolated in normal testis by differential mRNA display. TSGA10 is located on chromosome 2q11.2 and consists of 19 exons…”
Get full text
Journal Article -
12
XAGE-1 mRNA Expression in Prostate Cancer and Antibody Response in Patients
Published in Microbiology and immunology (2005)“…To evaluate the feasibility of cancer vaccine targeting XAGE‐1, we investigated the expression of 4 XAGE‐1 transcript variants and the humoral immune response…”
Get full text
Journal Article -
13
Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma
Published in Journal of gastroenterology and hepatology (01-10-2003)“…Background and Aim: Telomerase is the enzyme that synthesizes telomeric DNA, and the activation of telomerase is closely related to cellular immortality…”
Get full text
Journal Article -
14
Design and synthesis of 5-[(2-chloro-6-fluorophenyl)acetylamino]-3-(4-fluorophenyl)-4-(4-pyrimidinyl)isoxazole (AKP-001), a novel inhibitor of p38 MAP kinase with reduced side effects based on the antedrug concept
Published in Bioorganic & medicinal chemistry (01-08-2014)“…Inhibitors of p38 mitogen-activated protein (MAP) kinase, which are closely involved in the production of inflammatory cytokines, are considered promising…”
Get full text
Journal Article -
15
Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity
Published in Cancer immunity (13-11-2008)“…The prostate cancer HERV-K gag-related NGO-Pr-54 antigen was identified by SEREX analysis using autologous patient serum. NGO-Pr-54 mRNA was observed to be…”
Get full text
Journal Article -
16
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein
Published in Cancer immunity (19-04-2007)“…We recently showed that vaccination with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein (CHP-NY-ESO-1) elicited antibody…”
Get full text
Journal Article -
17
Halogen-Magnesium Exchange Reaction of Iodoindole Derivatives
Published in Heterocycles (1996)Get full text
Journal Article -
18
Prolonged survival of patients with lung adenocarcinoma expressing XAGE-1b and HLA class I antigens
Published in Cancer immunity (28-08-2008)“…XAGE-1b is a cancer/testis antigen that has been shown to be expressed at a significant frequency and to be immunogenic in non-small cell lung cancer (NSCLC)…”
Get full text
Journal Article -
19
Identification of XAGE-1 isoforms: predominant expression of XAGE-1b in testis and tumors
Published in Cancer immunity (05-03-2007)“…XAGE-1 is a cancer/testis (CT) antigen and has been shown to be immunogenic in lung cancer patients. Among 4 alternative splicing variants, XAGE-1a, b, c and…”
Get full text
Journal Article -
20
Identification of DR9-restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells
Published in International journal of oncology (01-04-2007)“…We previously demonstrated a dominant IgG response against XAGE-1b antigen in a lung cancer patient by serological analysis of antigens by recombinant…”
Get full text
Journal Article